Written by a 'Blue Ribbon' panel, the book addresses the wide range of advances in clinical practice for the climacteric in diagnostic technology and to therapeutic choices. At a time when ongoing research and clinical investigation into the use of HRT in perimenopausal women are incomplete--and when certain controversies remain unresolved--this summary of current opinion and knowledge fills the need for authoritative reference on this topic. Providing optimal assistance in determining an individual woman's risk profile, and properly assess the potential of therapeutic intervention, the book reviews the biological and practical rationale of all existing HRT agents.